Regardless of the uncertainty of specific regulation, which is likely context-dependent, it can be agreed that LRRK2 mutations, particularly G2019S, result in aberrant mitophagy within the PD context, likely contributing to its increased mitochondrial vulnerability and overall neurodegeneration156. Here, LRRK2 is linked to Parkinson disease.